Urologix Inc (ULGX)
0.00
USD |
OTCM |
May 03, 16:00
Urologix Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 03, 2024 | 4.84M |
May 02, 2024 | 4.84M |
May 01, 2024 | 4.84M |
April 30, 2024 | 4.84M |
April 29, 2024 | 4.84M |
April 26, 2024 | 4.84M |
April 25, 2024 | 4.84M |
April 24, 2024 | 4.84M |
April 23, 2024 | 4.84M |
April 22, 2024 | 4.84M |
April 19, 2024 | 4.84M |
April 18, 2024 | 4.84M |
April 17, 2024 | 4.84M |
April 16, 2024 | 4.84M |
April 15, 2024 | 4.84M |
April 12, 2024 | 4.84M |
April 11, 2024 | 4.84M |
April 10, 2024 | 4.84M |
April 09, 2024 | 4.84M |
April 08, 2024 | 4.84M |
April 05, 2024 | 4.84M |
April 04, 2024 | 4.84M |
April 03, 2024 | 4.84M |
April 02, 2024 | 4.84M |
April 01, 2024 | 4.84M |
Date | Value |
---|---|
March 28, 2024 | 4.84M |
March 27, 2024 | 4.84M |
March 26, 2024 | 4.84M |
March 25, 2024 | 4.84M |
March 22, 2024 | 4.84M |
March 21, 2024 | 4.84M |
March 20, 2024 | 4.84M |
March 19, 2024 | 4.84M |
March 18, 2024 | 4.84M |
March 15, 2024 | 4.84M |
March 14, 2024 | 4.84M |
March 13, 2024 | 4.84M |
March 12, 2024 | 4.84M |
March 11, 2024 | 4.84M |
March 08, 2024 | 4.84M |
March 07, 2024 | 4.84M |
March 06, 2024 | 4.84M |
March 05, 2024 | 4.84M |
March 04, 2024 | 4.84M |
March 01, 2024 | 4.84M |
February 29, 2024 | 4.84M |
February 28, 2024 | 4.84M |
February 27, 2024 | 4.84M |
February 26, 2024 | 4.84M |
February 23, 2024 | 4.84M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.84M
Minimum
Dec 31 2021
5.233M
Maximum
Feb 16 2021
4.894M
Average
4.844M
Median
Oct 13 2021
Enterprise Value Benchmarks
Perspective Therapeutics Inc | 1.055B |
Retractable Technologies Inc | -12.89M |
Xtant Medical Holdings Inc | 126.76M |
Asensus Surgical Inc | 44.48M |
Catheter Precision Inc | 0.8601M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -0.349M |
Revenue (Quarterly) | 2.796M |
Total Expenses (Quarterly) | 2.949M |
EPS Diluted (Quarterly) | -0.02 |